Samuel Durr
Cardiovascular Disease · Rapid City, SDNPI 1790731826
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.4% of the total across 85 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 16.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $850 and has fallen 97.7% since, to $20 in 2023. That places this record below the midpoint for cardiovascular disease clinicians in SD, where the typical reported total is $1,542.
Across 85 payments — averaging $18.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$259
- Medtronic$229
- Johnson & Johnson$188
- Chiesi USA, Inc.$158
- Abbott$141
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$139
- plus $428 from 10 others
Across 16 payments — averaging $8330.19 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AstraZeneca$81K
- Astrazeneca UK Limited$34K
- AbbVie$16K
- Eli Lilly$2K
What the payments were for
- Food & beverage$1,51798%
- Education$252%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 7 | $259 |
| Medtronic(2 entities) | 3 | $229 |
| Johnson & Johnson | 26 | $188 |
| Chiesi USA, Inc. | 15 | $158 |
| Abbott | 8 | $141 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 9 | $139 |
| Abiomed | 2 | $120 |
| W. L. Gore & Associates, Inc. | 1 | $91 |
| Amgen | 4 | $65 |
| Actelion Pharmaceuticals US, Inc. | 4 | $50 |
| Pfizer | 1 | $34 |
| Edwards Lifesciences | 1 | $16 |
| Lundbeck LLC | 1 | $15 |
| Angiodynamics, Inc. | 1 | $14 |
| Novartis | 1 | $12 |
| AstraZeneca | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- IN.PACT Admiral$214
- JARDIANCE$125
How this compares
$1,542 in reported general payments places this provider in the 50th percentile of 33 cardiovascular disease providers in South Dakota.
Other cardiovascular disease in Rapid City
- Bhaskar PurushottamRapid City$151K
- K HeilmanRapid City$5K
- Alexander SchabauerRapid City$4K
- Rajesh PradhanRapid City$3K
- Drew PurdyRapid City$2K
- Amid BitarRapid City$1K
- Stephen WasemillerRapid City$961
- Michael D'ursoRapid City$217
- Lewis FerrierRapid City$84
- Naveen RajpurohitSioux Falls$68K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.